Including results for abiomed investor relations
Search only for abmd investor relations
Investor relations. The J&J ... Information on tax basis following Kenvue separation. Questions? Please contact us: 1-800-950-5089 · investor-relations@its.jnj.
Abiomed® is committed to leading in technology and innovation, and improving patient outcomes by developing smaller, smarter and more connected technology.
People also ask
What happened to abmd?
How much will JNJ make in 2024?
Who acquired Abiomed?
What company makes Impella device?
Nov 1, 2022 · ... ABMD), a world leader in breakthrough heart ... Investor Conference Call. Johnson & Johnson ... Reach out to media relations or investor relations.
Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES.
abiomed announces q2 fy 2019 record revenue of $182 million, up ...
www.sec.gov › data › abmd-ex991_6
Director, Investor Relations. 978-646-1590. ir@abiomed.com. Tom Langford. Director, Communications & Public Relations. 978-882-8408. tlangford@abiomed.com ...
Nov 1, 2022 · “We are committed to investing for growth and look forward to welcoming the talented team and working together to foster our shared patient- ...
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
Nov 1, 2022 · Please note, you can find today's presentation on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com, following ...
Sep 22, 2022 · Chief Financial Officer. Nicole Nath. Manager, Investor Relations & FP&A. Chris Cooley, CFA. Managing Director. Medial Devices & Hospital Supply.
Sep 21, 2023 · ABIOMED INC has an Investment Rating of HOLD; a target price of $400.000000; an Industry Subrating of High; a Management Subrating of Medium ...
Missing: relations | Show results with:relations